Glen Eagle Advisors, LLC Neogenomics Inc Transaction History
Glen Eagle Advisors, LLC
- $650 Billion
- Q2 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 19,500 shares of NEO stock, worth $175,110. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,500
Previous 19,500
-0.0%
Holding current value
$175,110
Previous $185 Million
22.97%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
308Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$177 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$127 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$66.7 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$61.5 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$45.9 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.13B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...